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S U M M A R Y
Saint Louis encephalitis virus (SLEV) is a mosquito-borne ﬂavivirus from the Americas. In this report we
describe aspects of the laboratory diagnosis of a patient with an acute febrile illness induced by SLEV that
was initially diagnosed as dengue by positive IgM-ELISA. Infection with this virus is probably not rare in
Brazil, but cases remain undiagnosed. It is necessary to improve the surveillance system, including
laboratories, for the diagnosis of SLEV in Brazil.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Saint Louis encephalitis virus (SLEV) is an important mosquito-
borne ﬂavivirus in the Americas. When infecting man, SLEV can
produce disease ranging from a mild febrile illness to severe
encephalitis. SLEV was ﬁrst identiﬁed in Saint Louis, Missouri, USA,
in 1933.1 Several outbreaks have recently occurred in the
Americas, and the fatality rate has ranged from 5% to 20%. There
is no speciﬁc treatment or vaccine available for SLEV.2,3
The seroprevalence of SLEV in the Brazilian population ranges
from 3% to 43%.4,5 SLEV has also been reported to infect wild birds,
mosquitoes, and marsupials, and was recently isolated from the
brain of a horse with encephalitis in Minas Gerais State.6,7
Human disease induced by SLEV has rarely been reported in
Brazil. The ﬁrst case with a serological diagnosis occurred in Belem,
Para State, in 1978.8 Another case, diagnosed by RT-PCR, was
reported in Sao Paulo State (SP) in 2005.9 In 2006, an outbreak of
acute febrile disease with meningoencephalitis and/or hemor-
rhagic manifestations involving at least 14 cases was reported in
Sao Jose do Rio Preto, SP. Interestingly, this outbreak occurred* Corresponding author. Tel.: +55 16 3602 4580; fax: +55 16 3602 3376.
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).concomitantly with a large dengue outbreak.10,11 In this outbreak,
one case of co-infection with SLEV–dengue type 3 virus was
observed.12 Herein, we report SLEV infection in one patient living
in Ribeirao Preto, SP, Brazil.
2. Case report
In April 2008, a retired 74-year-old man sought medical care
after 24 h of fever, headache, diarrhea, muscle pain, arthralgia, and
lipothymia. The patient lived in the urban area of Ribeirao Preto,
had not been out of town in the last 15 days, and had been
vaccinated for yellow fever in 2003. The patient was clinically
diagnosed for dengue infection and a blood sample was collected
for laboratory diagnosis. The patient probably recovered without
sequelae.
The patient’s serum was ﬁrst tested by ELISA (Panbio, Brisbane,
Australia), showing IgM and IgG antibodies to dengue virus. The
serum was then tested for the presence of NS1 dengue antigen by
capture ELISA Platelia (Bio-Rad Laboratories, France), giving a
negative result. The dengue virus genome was not ampliﬁed in the
patient’s serum by conventional RT-PCR.13 Further investigations
were done for other ﬂaviviruses by ELISA and RT-PCR. Anti-SLEV
antibodies were detected by an in-house ELISA using recombinant
domain III (rDIII) of the envelope protein of the virus as antigen, as
reported previously.14 Corroborating these results, neutralizingciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Diagnosis of Saint Louis encephalitis virus in a patient with suspected dengue fever
Method Reference Result
Dengue IgM capture ELISA Panbio Reactive
Dengue IgG indirect ELISA Panbio Reactive
Dengue NS1 antigen
capture ELISA
Platelia-Bio-Rad Non-reactive
Dengue RT-PCR Lanciotti et al., 2002 Negative
SLEV in-house IgG ELISA Chaves et al., 2013 Reactive
Classic neutralization test Shope and Sather, 1979 Neutralizing
Flavivirus RT-PCR Bronzoni et al., 2005 Positive
SLEV, Saint Louis encephalitis virus.
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obtained in the serum by a classic neutralization test in baby mice
(Table 1).15
In addition, RNA was extracted from the patient’s serum using
the QIAamp viral RNA mini kit (Qiagen, Hilden, Germany) and was
subjected to an RT-PCR using non-structural protein 5 gene (NS5)
ﬂavivirus generic primers. An amplicon of approximately 800 base
pairs (bp) was obtained, as expected for a ﬂavivirus.16 The
amplicon was puriﬁed with the QIAquick gel extraction kit
(Qiagen, Hilden, Germany) and sequenced using the same
ﬂavivirus generic primers and the Big Dye Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems, Foster City, CA, USA) in a
sequencer Genetic Analyzer 3130 (Applied Biosystems, Foster City,
CA, USA). An 804-bp sequence was obtained and its SLEV origin
was conﬁrmed by BLAST (Basic Local Alignment Search Tool). This
nucleotide sequence was deposited in GenBank (accession number
KJ528400) and also compared to other NS5 SLEV sequences. The
sequence showed a very high identity (100%) with that of the SLEV
strain BeAn 246262 (GenBank accession number EU088424.1),
identiﬁed in a Didelphis marsupialis black-eared opossum in Belem,
Para State, in 1973. A high identity (100%) of the sequence with 800
nucleotides of the NS5 of SLEV identiﬁed in Sao Jose do Rio Preto
(EF219166.1; DQ836337.1; DQ836336.1) and high homology with
other Brazilian strains of SLEV was also observed.
3. Discussion
More than 10 pathogenic ﬂaviviruses have been described in
Brazil, with dengue viruses being those most commonly diag-
nosed.6 The acute benign febrile illness induced by SLEV, as
observed in our patient, could easily be confused with dengue in a
country where all four dengue virus serotypes circulate endemi-
cally. Public health authorities should be concerned about cross-
reactions of IgG and IgM antibodies to SLEV and other Brazilian
ﬂaviviruses in dengue serologic tests. This clinical presentation of
SLEV infection has also been reported by other authors.10,12,17 Our
patient did not develop meningoencephalitis, which is often
reported in persons over 60 years of age.10,12,17 It is possible that
many SLEV cases are not recognized mainly due to a cross-reaction
among ﬂaviviruses in serologic tests, including the dengue IgM
ELISA, as observed in the present patient. Thus, considering that
SLEV infection is probably not rare in Brazil and that the casesremain undiagnosed, it is necessary to improve the surveillance
system, including laboratories, for the diagnosis of SLEV in Brazil.
SLEV circulates in the state of Sao Paulo, the most populated
region of Brazil. This virus, probably brought in by birds, is
transmitted to man in urban areas by Culex mosquitoes. However,
the epidemiology of SLEV in urban areas is completely unknown.
Further studies are necessary to better understand the epidemiol-
ogy of SLEV in Brazil.
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